We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.74%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$20.8B
AUM Growth
+$3.81B
(+22%)
Cap. Flow
+$2.41B
Cap. Flow
% of AUM
11.56%
Top 10 Holdings %
Top 10 Hldgs %
30.36%
Holding
2,920
New
199
Increased
391
Reduced
1,521
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$974M |
| 2 |
Amazon
AMZN
|
+$604M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$220M |
| 4 |
Bank of America
BAC
|
+$83.7M |
| 5 |
Advanced Micro Devices
AMD
|
+$72.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$49.7M |
| 2 |
NVIDIA
NVDA
|
+$37.1M |
| 3 |
Microsoft
MSFT
|
+$33.4M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$28.9M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.99% |
| 2 | Financials | 13.3% |
| 3 | Consumer Discretionary | 10.8% |
| 4 | Healthcare | 9.36% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Pilgrim's Pride
PPC
$6.57B
| $894K | ﹤0.01% |
21,952
+229
| +1% | +$10.4K |
|
|
CDTX
1502
DELISTED
Cidara Therapeutics
CDTX
| $894K | ﹤0.01% |
9,334
-751
| -7% | -$47.9K |
|
1503
UFP Technologies
UFPT
$2.48B
| $894K | ﹤0.01% |
4,477
| – | – |
|
1504
Harrow
HROW
$1.48B
| $893K | ﹤0.01% |
18,542
| – | – |
|
1505
Amneal Pharmaceuticals
AMRX
$6.15B
| $892K | ﹤0.01% |
89,096
-5,841
| -6% | -$52.4K |
|
1506
Liquidia Corp
LQDA
$6.45B
| $887K | ﹤0.01% |
39,008
| – | – |
|
1507
Universal Technical Institute
UTI
$1.42B
| $886K | ﹤0.01% |
27,234
| – | – |
|
1508
Werner Enterprises
WERN
$2.31B
| $883K | ﹤0.01% |
33,549
-3,157
| -9% | -$88.5K |
|
|
SILA
1509
DELISTED
Sila Realty Trust
SILA
| $881K | ﹤0.01% |
35,106
-20
| -0.1% | -$498 |
|
|
STEL
1510
DELISTED
Stellar Bancorp
STEL
| $880K | ﹤0.01% |
29,013
-197
| -0.7% | -$5.99K |
|
1511
J&J Snack Foods
JJSF
$1.7B
| $880K | ﹤0.01% |
9,160
| – | – |
|
|
NVMI
1512
Nova
NVMI
$13.1B
| $880K | ﹤0.01% |
+2,759
| New | +$762K |
|
1513
Napco Security Technologies
NSSC
$1.37B
| $880K | ﹤0.01% |
20,478
-628
| -3% | -$21.8K |
|
1514
Pediatrix Medical
MD
$2.15B
| $879K | ﹤0.01% |
52,487
| – | – |
|
1515
Affirm
AFRM
$26.2B
| $879K | ﹤0.01% |
12,029
+297
| +3% | +$22.6K |
|
1516
HEICO Corp
HEI
$52.1B
| $877K | ﹤0.01% |
2,718
+79
| +3% | +$25.1K |
|
|
BELFB
1517
Bel Fuse Inc Class B
BELFB
$4.25B
| $877K | ﹤0.01% |
+6,221
| New | +$793K |
|
1518
Diebold Nixdorf
DBD
$2.45B
| $877K | ﹤0.01% |
15,379
| – | – |
|
1519
Comstock Resources
CRK
$3.99B
| $876K | ﹤0.01% |
44,175
| – | – |
|
|
ELME
1520
Elme Communities
ELME
$144M
| $876K | ﹤0.01% |
51,955
-2,939
| -5% | -$48.6K |
|
1521
Centuri Holdings
CTRI
$2.4B
| $874K | ﹤0.01% |
41,303
+30,782
| +293% | +$653K |
|
|
HTO
1522
H2O America
HTO
$2.65B
| $874K | ﹤0.01% |
17,952
-1,677
| -9% | -$83.7K |
|
1523
CONMED
CNMD
$1.49B
| $874K | ﹤0.01% |
18,575
| – | – |
|
|
XHR
1524
Xenia Hotels & Resorts
XHR
$1.73B
| $871K | ﹤0.01% |
63,481
-119
| -0.2% | -$1.62K |
|
1525
Ceco Environmental
CECO
$4.5B
| $871K | ﹤0.01% |
17,010
| – | – |
|
Similar funds
BA
FAM
VARA
CHP
MIC
OAG
MetLife Investment Management's Q3 2025 Portfolio in Review
As of Q3 2025, MetLife Investment Management held 2,920 positions worth $20.8B, up 22% from $17B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
MetLife Investment Management deployed $2.41B of net new capital in Q3 2025, opening 199 new positions and adding to 391 existing holdings. Its largest new stake was Apple: 4,311,733 shares worth $1.1B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $37.1M trimmed.
- MetLife Investment Management's largest Q3 2025 buy was Apple: 4,311,733 shares worth $1.1B.
- MetLife Investment Management added most to Applovin in Q3 2025, an estimated $29.1M increase.
- MetLife Investment Management's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $37.1M.
- MetLife Investment Management fully exited RTX Corp in Q3 2025, selling an estimated $49.7M.
- MetLife Investment Management's ten largest holdings make up 30% of its $20.8B portfolio in Q3 2025.
- MetLife Investment Management opened 199 new positions and closed 76 in Q3 2025.
- MetLife Investment Management's portfolio value rose 22% quarter-over-quarter to $20.8B.
Based on MetLife Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.